We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
+8.27%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$5.6B
AUM Growth
+$769M
(+16%)
Cap. Flow
+$469M
Cap. Flow
% of AUM
8.38%
Top 10 Holdings %
Top 10 Hldgs %
13.16%
Holding
1,266
New
125
Increased
352
Reduced
429
Closed
264
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$58.9M |
| 2 |
EOG Resources
EOG
|
+$37.7M |
| 3 |
Yum! Brands
YUM
|
+$29.2M |
| 4 |
Agilent Technologies
A
|
+$25.5M |
| 5 |
Occidental Petroleum
OXY
|
+$24.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gen Digital
GEN
|
+$27.1M |
| 2 |
Intercontinental Exchange
ICE
|
+$26M |
| 3 |
Global Payments
GPN
|
+$24.2M |
| 4 |
Cadence Design Systems
CDNS
|
+$22.8M |
| 5 |
Apple
AAPL
|
+$22.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.55% |
| 2 | Financials | 15.15% |
| 3 | Healthcare | 14.96% |
| 4 | Consumer Discretionary | 10.52% |
| 5 | Industrials | 10.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
626
Vertex Pharmaceuticals
VRTX
$121B
| $767K | 0.01% |
+8,790
| New | +$831K |
|
627
Ingles Markets
IMKTA
$1.63B
| $764K | 0.01% |
19,324
-15,467
| -44% | -$594K |
|
|
RATE
628
DELISTED
Bankrate Inc
RATE
| $764K | 0.01% |
90,038
+53,600
| +147% | +$426K |
|
629
Ecolab
ECL
$75.6B
| $757K | 0.01% |
6,220
| – | – |
|
|
TGH
630
DELISTED
Textainer Group Holdings limited
TGH
| $755K | 0.01% |
100,855
+25,800
| +34% | +$255K |
|
|
FRGI
631
DELISTED
Fiesta Restaurant Group, Inc.
FRGI
| $750K | 0.01% |
+31,230
| New | +$755K |
|
|
BGFV
632
DELISTED
Big 5 Sporting Goods
BGFV
| $749K | 0.01% |
54,969
+3,900
| +8% | +$47.8K |
|
633
Insight Enterprises
NSIT
$3.55B
| $742K | 0.01% |
22,791
-17,580
| -44% | -$517K |
|
634
BancFirst
BANF
$3.92B
| $741K | 0.01% |
20,432
| – | – |
|
635
TTM Technologies
TTMI
$13.6B
| $739K | 0.01% |
64,544
| – | – |
|
|
SYNT
636
DELISTED
Syntel Inc
SYNT
| $731K | 0.01% |
17,445
-13,973
| -44% | -$625K |
|
|
EXPR
637
DELISTED
Express, Inc.
EXPR
| $730K | 0.01% |
3,095
-2,980
| -49% | -$808K |
|
638
Quantum Corp
QMCO
$437M
| $728K | 0.01% |
6,176
-823
| -12% | -$80.4K |
|
|
TRST
639
Trustco Bank Corp NY
TRST
$977M
| $725K | 0.01% |
20,460
-3,759
| -16% | -$129K |
|
640
GE Aerospace
GE
$367B
| $724K | 0.01% |
5,101
-386
| -7% | -$57.6K |
|
641
Merit Medical Systems
MMSI
$4.43B
| $722K | 0.01% |
29,729
-200
| -0.7% | -$4.62K |
|
642
Chevron
CVX
$388B
| $721K | 0.01% |
7,010
-25,200
| -78% | -$2.57M |
|
643
TETRA Technologies
TTI
$1.23B
| $716K | 0.01% |
117,233
+700
| +0.6% | +$4.26K |
|
|
FL
644
DELISTED
Foot Locker
FL
| $714K | 0.01% |
10,550
-20
| -0.2% | -$1.25K |
|
|
TUBE
645
DELISTED
TubeMogul, Inc.
TUBE
| $711K | 0.01% |
+75,860
| New | +$766K |
|
646
New York Times
NYT
$11.6B
| $710K | 0.01% |
59,400
-209,358
| -78% | -$2.65M |
|
|
INVX
647
Innovex International
INVX
$1.87B
| $706K | 0.01% |
12,670
+1,170
| +10% | +$65.3K |
|
648
Element Solutions
ESI
$9.12B
| $705K | 0.01% |
86,900
+70,100
| +417% | +$625K |
|
|
P
649
Everpure Inc
P
$24.8B
| $703K | 0.01% |
51,850
+18,390
| +55% | +$230K |
|
|
IBTX
650
DELISTED
Independent Bank Group, Inc.
IBTX
| $694K | 0.01% |
15,720
| – | – |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q3 2016 Portfolio in Review
As of Q3 2016, Jacobs Levy Equity Management held 1,266 positions worth $5.6B, up 16% from $4.83B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Jacobs Levy Equity Management deployed $469M of net new capital in Q3 2016, opening 125 new positions and adding to 352 existing holdings. Its largest new stake was Bristol-Myers Squibb: 916,932 shares worth $49.4M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 18% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Intercontinental Exchange, an estimated $26M trimmed.
- Jacobs Levy Equity Management's largest Q3 2016 buy was Bristol-Myers Squibb: 916,932 shares worth $49.4M.
- Jacobs Levy Equity Management added most to Agilent Technologies in Q3 2016, an estimated $25.5M increase.
- Jacobs Levy Equity Management's biggest Q3 2016 reduction was Intercontinental Exchange, cutting an estimated $26M.
- Jacobs Levy Equity Management fully exited Gen Digital in Q3 2016, selling an estimated $27.1M.
- Jacobs Levy Equity Management's ten largest holdings make up 13% of its $5.6B portfolio in Q3 2016.
- Jacobs Levy Equity Management opened 125 new positions and closed 264 in Q3 2016.
- Jacobs Levy Equity Management's portfolio value rose 16% quarter-over-quarter to $5.6B.
Based on Jacobs Levy Equity Management's 13F filing for Q3 2016, filed 14 Nov 2016.